Huafang Li

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Machine Learning

Placebo Controlled

Top Venues

Translational psychiatry

Neuropsychiatric disease and treatment

European journal of drug metabolism and pharmacokinetics

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Yimin Yu, Jingjing He, Zhiwei Huang, Yan Li, Ying Wu, Yifeng Shen, Yanling Zhou, Cungang Bao, Zhiping Jin, Huafang Li
Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration. Expert opinion on investigational drugs (2023)
Shen He, Yue Shi, Jinmei Ye, Jiahui Yin, Yufang Yang, Dan Liu, Ting Shen, Duan Zeng, Min Zhang, Siyuan Li, Feikang Xu, Yiyun Cai, Faming Zhao, Huafang Li, Dai-Hui Peng
Does decreased autophagy and dysregulation of LC3A in astrocytes play a role in major depressive disorder? Translational psychiatry 13 (1) (2023)
Yange Li, Lei Zhang, Yan Zhang, Hui Wen, Jingjing Huang, Yifeng Shen, Huafang Li
A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study. Neuropsychiatric disease and treatment 17 (2021)
Fan Zhang, Yan Li, Jingqiu Hu, Jinhua Zhong, Huafang Li
Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers. European journal of drug metabolism and pharmacokinetics 44 (3) (2019)